Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles by Hung-Yao Lin, Tai-Chung Tseng

Subjects: “…tenofovir disoproxil fumarate…”
Get full text

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study by Giacomo Stroffolini, Valentina Dodaro, Amedeo De Nicolò, Jessica Cusato, Giovanni Di Perri, Antonio D'Avolio, Lucio Boglione

Subjects: Get full text

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate. by Linn Hermansson, Aylin Yilmaz, Richard W Price, Staffan Nilsson, Scott McCallister, Tariro Makadzange, Moupali Das, Henrik Zetterberg, Kaj Blennow, Magnus Gisslen

“…<h4>Background</h4>Because tenofovir alafenamide (TAF) leads to significantly lower plasma tenofovir concentrations than tenofovir disoproxil fumarate (TDF) and is a stronger substrate for P-glycoprotein (P-gp) than TDF, TAF could lead to decreased central nervous system (CNS) tenofovir exposure than TDF. …”
Get full text

Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece by Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, Sushanth Jeyakumar, Nathaniel J Smith, Alon Yehoshua, Evangelos Cholongitas

Subjects:

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV by Ashana Puri, Sonalika A. Bhattaccharjee, Wei Zhang, Meredith Clark, Onkar N. Singh, Gustavo F. Doncel, Ajay K. Banga

Subjects: Get full text

Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy by Dorward, J, Govender, K, Moodley, P, Lessells, R, Samsunder, N, Sookrajh, Y, Fanshawe, TR, Turner, PJ, Butler, CC, Drain, PK, Hayward, GN, Garrett, N

“…<p><strong>Objective:</strong>&nbsp;We aimed to determine whether urine tenofovir (TFV) and dried blood spot (DBS) tenofovir diphosphate (TFV-DP) concentrations are associated with concurrent HIV viraemia.…”

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study by Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Siou-Ping Huang, Hsu-Heng Yen

Subjects: “…Tenofovir Disoproxil Fumarate…”
Get full text

Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV by Jared M. Gilbert, Kirsten Vest, Troy D. Kish

Subjects: Get full text

Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients by He J, Guo Y, Zhang Y, Han J, Chen J, Jia Y, Ma Z, Wu J, Zhang S, Li F, Mao R, Zhang J

Subjects: Get full text

Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV by Nicole Marie Lioufas, Alan Street, Paul Champion de Crespigny, Stephen G Holt

Subjects: “…Tenofovir…”
Get full text

A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate. by Kuo-Hsiung Yang, Craig Hendrix, Namandje Bumpus, Julie Elliott, Karen Tanner, Christine Mauck, Ross Cranston, Ian McGowan, Nicola Richardson-Harman, Peter A Anton, Angela D M Kashuba

“…All received a single 300-mg dose of oral tenofovir disoproxil fumarate (TDF) and were then randomized 2:1 to receive single and then seven daily rectal exposures of vaginally-formulated tenofovir (TFV) 1% gel or a hydroxyethyl cellulose (HEC) placebo gel. …”
Get full text

Assessment of treatment outcomes for HIV Positives transitioned from Tenofovir/Lamivudine/Efavirenz to Tenofovir/Lamivudine/Dolutegravir in a Nigerian Tertiary Hospital by Omobola Yetunde Ojo, AbdulMumin Ahmed, Adeyinka Adeniran, Olarenwaju Olusola Onigbogi, Modupe Olajumoke Onigbogi, Kamil Olanipekun Alausa

“… Objective: Dolutegravir, an integrase inhibitor replaced nevirapine or efavirenz (both NRTIs) in a fixed dose combination with Tenofovir/Lamivudine, as the preferred first-line option for the prevention and treatment of HIV infection. …”
Get full text

Tenofovir treatment of the severe acute hepatitis B Tratamiento con tenofovir de la hepatitis aguda B de evolución grave by Fernando Casals-Seoane, Beatriz Arberas-Díez, Luisa García-Buey

Get full text

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen by Keene, CM, Griesel, R, Zhao, Y, Gcwabe, Z, Sayed, K, Hill, A, Cassidy, T, Ngwenya, O, Jackson, A, van Zyl, G, Schutz, C, Goliath, R, Flowers, T, Goemaere, E, Wiesner, L, Simmons, B, Maartens, G, Meintjes, G

“…We evaluated efficacy of tenofovir/lamivudine/dolutegravir (TLD) in patients failing first-line tenofovir/XTC/efavirenz or nevirapine. …”

The Role of Drug Transporters in the Kidney: Lessons from Tenofovir by Darren Michael Moss, Megan eNeary, Andrew eOwen

Subjects: Get full text

An overview of tenofovir and renal disease for the HIV-treating clinician by Willem D.F. Venter, June Fabian, Charles Feldman

Subjects: “…tenofovir…”
Get full text

Acute generalised exanthematous pustulosis secondary to cotrimoxazole or tenofovir by J Black, R Kruger, R Roberts, R Lehloenya, M Mendelson

“…We present a rare case of acute generalised exanthematous pustulosis secondary to cotrimoxazole or tenofovir.…”
Get full text

Release of Tenofovir from Carrageenan-Based Vaginal Suppositories by Toral Zaveri, John E. Hayes, Gregory R. Ziegler

Subjects: Get full text

The genotoxicity of Tenofovir disoproxil fumarate in HBV-infected patients by Selcen Korkmaz, Sengul Yuksel, Yasemin Ersoy

Subjects: “…Tenofovir disoproxil fumarate…”
Get full text

Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir by Giuseppe Coppolino, Valeria Cernaro, Laura Rivoli, Angela Pinciaroli, Davide Bolignano

“…Tenofovir, a third generation oral nucle(t)oside analogue, currently represents one of the first-line drugs recommended for treating chronic hepatitis B (HBV) infection. …”
Get full text